Elasmogen, which is part of the Deepbridge Life Sciences EIS portfolio, are to collaborate with the University of Aberdeen as partner on a Scottish research award to assist with critical research to tackle the COVID-19 pandemic.
We are pleased to announce that VoxSmart, which is part of the Deepbridge Technology Growth EIS portfolio, has been classified as 'enterprise critical' and essential for business continuity by the financial institutions in the Asia Pacific (APAC) region during the world
Last year, arbnco, which is part of the Deepbridge Technology Growth EIS portfolio, announced a collaboration with Arc Skoru Inc. to help rate the operational performance of buildings through indoor environmental monitoring.
Elasmogen, which is part of the Deepbridge Life Sciences EIS portfolio, have announced a collaboriation with Intract Pharma Limited London, to discover and develop novel orally-delivered protein therapeutics, which will incorporate proprietary technologies developed by each company.
Picturepath, which is part of the Deepbridge Life Sciences EIS fund, is aiming to help autistic children during lockdown through an online app that founder, Richard Nurse, originally created for his son with the aim to reduce his anxiety.
Deepbridge is delighted to commit £1m to a £2.25m funding round by existing investee company Liverpool ChiroChem. We are pleased to be joined by funding partners from Praetura Ventures and NPIF - Maven Equity Finance, which is managed by Maven and part of the Northern Powerhouse Investment Fund, as part of the funding round.